Using geospatial modeling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa
暂无分享,去创建一个
Sally Blower | David J. Gerberry | W. Heneine | S. Blower | B. Wagner | Walid Heneine | Bradley G. Wagner | J. Gerardo Garcia-Lerma | J. García-Lerma
[1] J. Yorke,et al. Gonorrhea Transmission Dynamics and Control , 1984 .
[2] L. V. Van Bortel,et al. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. , 2009, AIDS research and human retroviruses.
[3] A. Wald,et al. Genital herpes and human immunodeficiency virus: double trouble. , 2004, Bulletin of the World Health Organization.
[4] J. Changalucha,et al. The epidemiology of HIV among young people in sub-Saharan Africa: know your local epidemic and its implications for prevention. , 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[5] A. Nizam,et al. Containing Bioterrorist Smallpox , 2002, Science.
[6] Robert C. Wolpert,et al. A Review of the , 1985 .
[7] D. Ho,et al. Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus , 2014, Science.
[8] Lynn Morris,et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.
[9] R. Mackie,et al. Double trouble. , 1989, Nursing times.
[10] David V Glidden,et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.
[11] L. Corey. Synergistic copathogens--HIV-1 and HSV-2. , 2007, The New England journal of medicine.
[12] S. Blower,et al. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: The effect of the urban–rural divide , 2006, Proceedings of the National Academy of Sciences.
[13] Hadi Dowlatabadi,et al. Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .
[14] H. Weiss,et al. The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis , 2011, AIDS.
[15] Sally Blower,et al. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis , 2010, Proceedings of the National Academy of Sciences.
[16] Arielle Lasry,et al. A model for allocating CDC’s HIV prevention resources in the United States , 2011, Health care management science.
[17] S. A. Abdool Karim,et al. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial , 2011, Trials.
[18] S. Blower,et al. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control , 2012, AIDS.
[19] R. Walensky,et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] S. Blower,et al. Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in Sub-Saharan Africa , 2013, BMC Medicine.
[21] Dirk P. Kroese,et al. Controlling the number of HIV infectives in a mobile population. , 2008, Mathematical biosciences.
[22] A. Wald,et al. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. , 2002, The Journal of infectious diseases.
[23] T. Fako,et al. The geography of HIV/AIDS prevalence rates in Botswana , 2012, HIV/AIDS.
[24] Mapping HIV epidemics in sub-Saharan Africa with use of GPS data. , 2013, The Lancet. Global health.
[25] R. Walensky,et al. The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa , 2011, Journal of acquired immune deficiency syndromes.
[26] A. Mindel,et al. Epidemiology of herpes and HIV co-infection. , 2004, Journal of HIV therapy.
[27] R. Berg,et al. A Systematic Review and Meta-analysis , 2010 .
[28] Ashley A. Eggman,et al. Cost–effectiveness of pre-exposure prophylaxis for HIV: a review , 2012, Current opinion in HIV and AIDS.
[29] John T Brooks,et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.
[30] Erin N. Bodine,et al. Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco , 2010, Science.
[31] B. Herold,et al. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges , 2013, Proceedings of the National Academy of Sciences.
[32] James D. Campbell,et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.
[33] Richard J Hayes,et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.
[34] J.-J. Simond,et al. Double trouble , 1999, IEEE Industry Applications Magazine.
[35] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[36] S. Self,et al. Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa , 2008, PloS one.
[37] F. Schmidt. Meta-Analysis , 2008 .
[38] R. Walensky,et al. Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. , 2012, The Journal of infectious diseases.
[39] L. Alkema,et al. A Bayesian approach to uncertainty analysis of sexually transmitted infection models , 2009, Sexually Transmitted Infections.
[40] R. Walensky,et al. The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.